-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators. -
Guideline‐Directed Medical Therapy for Patients With Heart Failure With Midrange Ejection Fraction: A Patient‐Pooled Analysis From the KorHF and KorAHF RegistriesKi Hong Choi Jin‐Oh Choi et al.
-
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future DirectionsHsu JJ, Ziaeian B, Fonarow GC.
-
Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of AmericaDunlay SM, Givertz MM, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and the Heart Failure Society of America.
-
Mechanical circulatory support devices in advanced heart failure: 2020 and beyondJL Vieira, HO Ventura, MR Mehra et al.
-
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection FractionJ Tromp, L Shen, PS Jhund et al.
-
Association of Abnormal Left Ventricular Functional Reserve With Outcome in Heart Failure With Preserved Ejection FractionKosmala W, Przewlocka-Kosmala M, Marwick TH et al.
-
Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failureCR Olsen, RJ Mentz, KJ Anstrom et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
